Summary
In vitro studies on purified rat beta cells have indicated a functional diversity among insulincontaining cells. Intercellular differences were found in the rates of glucose-induced insulin synthesis and release. They are attributed to differences in cellular thresholds for glucose utilization and oxidation, as can be caused by varying activities in rate limiting steps such as glucokinase-dependent phosphorylation. The percent of functionally active beta cells increases dose-dependently with the glucose concentration, making cellular heterogeneity and its regulation by glucose major determinants for the dose-response curves of the total beta-cell population. Beta cells which are already responsive to low glucose concentrations are characterized by a higher content in pale immature granules; their activated biosynthetic and secretory activity accounts for preferential release of newly-formed hormone by the total beta-cell population. At any glucose level, the amplitude of insulin release depends on the percent glucose-activated cells and their cyclic AMP content, an integrator of (neuro)hormonal influences. The in vitro described heterogeneity in beta-cell functions may bear physiological relevance as several of its characteristics are also detectable in intact pancreatic tissue; furthermore, in vitro signs of heterogeneity can be altered by prior in vivo treatment indicating that they express properties of the cells in their in situ configuration. Elevated basal levels of (pro)insulin may reflect the existence of an increased number of beta cells that are activated at low physiologic glucose concentrations. Reductions in stimulated insulin levels can be caused by decreased numbers of beta cells that are activated at the prevailing glucose concentration or by insufficient cyclic AMP levels in beta cells, possibly as a result of inadequate signalling from hormones of local or distal origin. Only few markers are currently available with which to explore these mechanisms in vivo. Additional markers and tests should help assess the possible role of variations in beta-cell heterogeneity in the pathogenesis of diabetes mellitus.
Article PDF
Similar content being viewed by others
Abbreviations
- GLP-1:
-
Glucagon-like peptide-1
References
Pipeleers D (1987) The biosociology of pancreatic B cells (Minkowski Lecture). Diabetologia 30: 277–291
Pipeleers D, Van De Winkel M (1986) Pancreatic B-cells possess defense mechanisms against cell-specific toxicity. Proc Natl Acad Sci 83: 5267–5271
Pipeleers D, Schuit F, In't Veld P, Maes E, Hooghe-Peters E, Van de Winkel M, Gepts W (1985) Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology 117: 824–833
Schuit F, Pipeleers D (1986) Differences in adrenergic recognition by pancreatic A and B cells. Science 232: 875–877
Pipeleers D (1986) Purified islet cells in diabetes research. Horm Res 23: 225–234
Schuit F, Pipeleers D (1985) Regulation of adenosine 3′,5′-monophosphate levels in the pancreatic B cell. Endocrinology 117: 834–840
Unger RH, Eisentraut AM (1969) Entero-insular axis. Arch Intern Med 123: 261–266
Perley MJ, Kipnis DM (1967) Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest 46: 1954–1962
Creutzfeldt W (1979) The incretin concept today. Diabetologia 16: 75–85
Dupré Ross JSA, Watson D, Brown JC (1973) Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 37: 826–828
Mojsov S, Weir GC, Habener JF (1987) Insulinotropin: glucagon-like peptide 1 (7–37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79: 616–619
Kreymann B, Ghatei MA, Williams G, Bloom SR (1987) Glucagon-like peptide 1 7–36: a physiological incretin in man. Lancet 22: 1300–1304
Holz IV GG, Kühtreiber WM, Habener JF (1993) Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7–37). Nature 361: 362–365
Thorens B, Waeber G (1993) Glucagon-like peptide-1 and the control of insulin secretion in the normal state and in NIDDM. Diabetes 42: 1219–1225
Schmidt WE, Siegel EG, Creutzfeldt W (1985) Glucagonlike peptide-A but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28: 704–707
Jones IR, Owens DR, Moody AJ, Luzio SD, Morris T, Hayes TM (1987) The effects of glucose-dependent insulinotropic peptide infused at physiological concentrations in normal subjects and type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion. Diabetologia 30: 707–712
Drucker DJ, Philippe J, Moisov S, Chick WL, Habener JF (1987) Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA 84: 3434–3438
Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 (7–36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91: 301–307
Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt WO (1993) Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7–36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 741–744
Thorens B, Porret A, Bühler L, Deng SP, Morel Ph, Widmann C (1993) Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9–39) an antagonist of the receptor. Diabetes 42: 1678–1682
Van De Winkel M, Pipeleers D (1983) Autofluorescenceactivated cell sorting of pancreatic islet cells: purification of insulin-containing B-cells according to glucose-induced changes in cellular redox state. Biochem Biophys Res Commun 114: 835–842
Pipeleers D, Van De Winkel M (1989) Cellular endogenous fluorescence: a basis for preparing subpopulations of functionally homogenous cells. In: Kohen E (ed) Cell structure and function by microspectrofluorometry. Academic Press, pp 391–404
Kiekens R, In't Veld P, Mahler T, Schuit F, Van De Winkel M, Pipeleers D (1992) Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J Clin Invest 89: 117–125
Schuit F, In't Veld P, Pipeleers D (1988) Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci USA 85: 3865–3869
Beigelman PM, Ribalet B, Atwater I (1977) Electrical activity of mouse pancreatic beta-cells: II. Effects of glucose and arginine. J Physiol 73: 201–217
Pralong WF, Bartley C, Wollheim CB (1990) Single islet B cell stimulation by nutrients relationship beteween pyridine nucleotides, cytosolin Ca2+ and secretion. EMBO J. 9: 53–60
Hellman B, Gylfe E, Grapengieser E, Lund PE, Bert A (1992) Cytoplasmic Ca2+ oscillations in pancreatic β-cells. Biochem Biophys Acta 1113: 295–305
Salomon D, Meda P (1986) Heterogeneity and contact-dependent regulation of hormone secretion by individual B cells. Exp Cell Res 162: 507–526
Hiriart M, Matterson R (1988) Na+ channels and two types of Ca 2 + channels in rat pancreatic β-cells identified worth the reverse hemolytic plaque assay. J Gen Physiol 41: 617–639
Bosco D, Meda P (1991) Actively synthesizing B-cells secrete preferentially after glucose stimulation. Endocrinology 129: 2193–2198
Hiriart M, Ramires-Medeles MC (1991) Functional subpopulations of individual pancreatic β cells in culture. Endocrinology 128: 3193–3198
Van Schravendijk CFH, Kiekens R, Pipeleers D (1992) Pancreatic β cell heterogeneity in glucose-induced insulin secretion. J Biol Chem 267: 21344–21348
Pipeleers D (1992) Heterogeneity in pancreatic β-cell population. Diabetes 41: 777–781
Heimberg H, De Vos A, Vandercammen A, Van Schaftingen E, Pipeleers D, Schuit F (1993) Heterogeneity in glucose sensitivity among pancreatic β-cells is correlated to differences in glucose phosphorylation rather than glucose transport. EMBO J 12: 2873–2879
Giordane G, Cirulli V, Bosco D, Rouiller D, Halban P, Meda P (1993) B-cell size influences glucose-stimulated insulin secretion. Am J Physiol 265: C358-C364
Pipeleers DG, Pipeleers-Marichal M, Hannaert JC, Berghmans M, In't Veld PA, Rozing J, Van De Winkel M, Gepts W (1991) Transplantation of purified islet cells in diabetic rats. 1. Standardization of islet cell grafts. Diabetes 40: 908–919
Meda P, Halban P, Perrelet A, Renold AE, Orci L (1980) Gap junction development is correlated with insulin content in the pancreatic β cell. Science 209: 1026–1028
Tielemans D, Pipeleers D (1993) Treatment of normal rats with glibenclamide recruits islet β cells for increased insulin biosynthetic activity. Diabetologia 36 [Suppl 1]: A66 (Abstract)
Grodsky GM (1972) A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest 51: 2047–2059
Pipeleers D, Ling Z (1992) Pancreatic β cells in insulin-dependent diabetes. Diab Metab Rev 8: 209–227
Stefan Y, Meda P, Menfeld M, Orci L (1987) Stimulation of insulin secretion reveals heterogeneity of pancreatic B cells in vivo. J Clin Invest 80: 175–183
Orci L (1985) The insulin factory atour of the plant surroundings and a visit to the assembidy line. Diabetologia 28: 328–346
Hellerström C, Swenne I (1985) Growth pattern of pancreatic islets in animals. In: Volk BW, Arquilla G (eds) The diabetic pancreas. Plenum, New York, pp 53–79
Matchinsky FM (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic β cells and hepatocytes. Diabetes 39: 647–652
Randle PJ (1993) Glucokinase and candidate genes for type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 269–275
Jetton TL, Magnuson MA (1992) Heterogenean expression of glucokinase among pancreatic beta cells. Proc Natl Acad Sci USA 89: 2619–2623
Bencosme SA, Mortinez-Palormo A (1968) Formation of secretory granules in pancreatic islet B cells of cortisonetreated rabbits. Lab Invest 18: 746–756
Bencosme SA, Tsutsumi V, Martin JM, Åkerblom HK (1971) Ultrastructural changes in B cells of pancreatic islets from rats with elevated levels of circulating growth hormone secreted by MtT-W15 tumor. Diabetes 20: 15–26
Shino A, Matsmo T, Iwatsuka H, Suzuoki Z (1973) Structural changes of pancreatic islets in genetically obese rats. Diabetologia 9: 413–421
Aerts L, Van Assche FA (1975) Ultrastructural changes of the endocrine pancreas in pregnant rats. Diabetologia 11: 285–289
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pipeleers, D., Kiekens, R., Ling, Z. et al. Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 37 (Suppl 2), S57–S64 (1994). https://doi.org/10.1007/BF00400827
Issue Date:
DOI: https://doi.org/10.1007/BF00400827